EyePoint Pharmaceuticals (EYPT) Stock Forecast for 2023 – 2026. Sell or Buy?
Updated: December 3, 2023 (09:52)
Sector: HealthcareThe share price of EyePoint Pharmaceuticals, Inc. (EYPT) now
50/200 Day Moving Average: $7.63 / $7.3
This figure corresponds to the Average Price over the previous 50/200 days. For EyePoint Pharmaceuticals stocks, the 50-day moving average is the resistance level today.
For EyePoint Pharmaceuticals stocks, the 200-day moving average is the resistance level today.
Are you interested in EyePoint Pharmaceuticals, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the EyePoint Pharmaceuticals stock price in 2023, 2024, 2025, 2026, 2027. How much will one EyePoint Pharmaceuticals share be worth in 2023 - 2027?
When should I take profit in EyePoint Pharmaceuticals stock? When should I record a loss on EyePoint Pharmaceuticals stock? What are analysts' forecasts for EyePoint Pharmaceuticals stock? What is the future of EyePoint Pharmaceuticals stock? We forecast EyePoint Pharmaceuticals stock performance using neural networks based on historical data on EyePoint Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
EyePoint Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for EyePoint Pharmaceuticals shares. This happens once a day.
Historical and forecast chart of EyePoint Pharmaceuticals stock
The chart below shows the historical price of EyePoint Pharmaceuticals stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the EyePoint Pharmaceuticals stock price can be found in the table below.
Long-term forecasts by years.
EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development and commercializing of ophthalmic products. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.
EyePoint Pharmaceuticals daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Dec 05 | 7.17 | 6.91 | 7.24 | 4.77 |
| Dec 06 | 7.08 | 6.83 | 7.34 | 7.58 |
| Dec 07 | 7.10 | 6.87 | 7.35 | 7.03 |
| Dec 08 | 7.16 | 6.88 | 7.26 | 5.41 |
| Dec 09 | 7.25 | 7.06 | 7.49 | 6.11 |
| Dec 10 | 7.43 | 7.20 | 7.64 | 6.14 |
| Dec 11 | 7.59 | 7.32 | 7.73 | 5.60 |
| Dec 12 | 7.76 | 7.52 | 7.93 | 5.47 |
| Dec 13 | 7.53 | 7.41 | 7.73 | 4.27 |
| Dec 14 | 7.18 | 7.07 | 7.41 | 4.82 |
| Dec 15 | 6.98 | 6.75 | 7.08 | 4.81 |
| Dec 16 | 6.90 | 6.72 | 7.11 | 5.90 |
| Dec 17 | 7.10 | 6.97 | 7.22 | 3.62 |
| Dec 18 | 6.95 | 6.72 | 7.08 | 5.27 |
| Dec 19 | 6.78 | 6.70 | 7.05 | 5.32 |
| Dec 20 | 6.67 | 6.56 | 6.94 | 5.80 |
| Dec 21 | 6.85 | 6.71 | 6.92 | 3.17 |
| Dec 22 | 6.83 | 6.60 | 6.95 | 5.39 |
| Dec 23 | 6.83 | 6.66 | 7.01 | 5.28 |
| Dec 24 | 6.51 | 6.34 | 6.64 | 4.67 |
| Dec 25 | 6.37 | 6.27 | 6.49 | 3.56 |
| Dec 26 | 6.16 | 5.94 | 6.33 | 6.54 |
| Dec 27 | 6.08 | 5.92 | 6.14 | 3.69 |
| Dec 28 | 6.38 | 6.20 | 6.44 | 3.86 |
| Dec 29 | 6.31 | 6.13 | 6.41 | 4.63 |
| Dec 30 | 6.38 | 6.13 | 6.47 | 5.57 |
| Dec 31 | 6.23 | 6.00 | 6.37 | 6.13 |
| Jan 01 | 6.16 | 6.04 | 6.29 | 4.18 |
| Jan 02 | 5.99 | 5.82 | 6.11 | 4.89 |
| Jan 03 | 5.93 | 5.86 | 6.13 | 4.60 |
EyePoint Pharmaceuticals Daily Price Targets
EyePoint Pharmaceuticals Stock Forecast 12-05-2023.
Forecast target price for 12-05-2023: $7.17.
Positive dynamics for EyePoint Pharmaceuticals shares will prevail with possible volatility of 4.552%.
Pessimistic target level: 6.91
Optimistic target level: 7.24
EyePoint Pharmaceuticals Stock Forecast 12-06-2023.
Forecast target price for 12-06-2023: $7.08.
Negative dynamics for EyePoint Pharmaceuticals shares will prevail with possible volatility of 7.043%.
Pessimistic target level: 6.83
Optimistic target level: 7.34
EyePoint Pharmaceuticals Stock Forecast 12-07-2023.
Forecast target price for 12-07-2023: $7.10.
Positive dynamics for EyePoint Pharmaceuticals shares will prevail with possible volatility of 6.567%.
Pessimistic target level: 6.87
Optimistic target level: 7.35
EyePoint Pharmaceuticals Stock Forecast 12-08-2023.
Forecast target price for 12-08-2023: $7.16.
Positive dynamics for EyePoint Pharmaceuticals shares will prevail with possible volatility of 5.128%.
Pessimistic target level: 6.88
Optimistic target level: 7.26
EyePoint Pharmaceuticals Stock Forecast 12-09-2023.
Forecast target price for 12-09-2023: $7.25.
Positive dynamics for EyePoint Pharmaceuticals shares will prevail with possible volatility of 5.757%.
Pessimistic target level: 7.06
Optimistic target level: 7.49
EyePoint Pharmaceuticals Stock Forecast 12-10-2023.
Forecast target price for 12-10-2023: $7.43.
Positive dynamics for EyePoint Pharmaceuticals shares will prevail with possible volatility of 5.785%.
Pessimistic target level: 7.20
Optimistic target level: 7.64
EYPT (EYPT) Monthly Stock Prediction for 2023
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Dec. | 6.49 | 5.59 | 7.36 | 24.11 |
EyePoint Pharmaceuticals forecast for this year
EyePoint Pharmaceuticals Stock Prediction for Dec 2023
An downtrend is forecast for this month with an optimal target price of $6.48886. Pessimistic: $5.59. Optimistic: $7.36
EyePoint Pharmaceuticals (EYPT) Monthly Stock Prediction for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 7.36 | 6.26 | 7.69 | 18.57 |
| Feb | 7.42 | 7.11 | 8.14 | 12.64 |
| Mar | 7.27 | 6.41 | 7.62 | 15.93 |
| Apr | 6.71 | 5.92 | 7.30 | 18.87 |
| May | 7.18 | 6.31 | 8.02 | 21.28 |
| Jun | 8.29 | 7.60 | 9.20 | 17.46 |
| Jul | 7.53 | 6.82 | 8.32 | 18.06 |
| Aug | 7.81 | 6.78 | 8.74 | 22.40 |
| Sep | 6.99 | 6.43 | 7.36 | 12.63 |
| Oct | 5.94 | 5.55 | 6.77 | 18.02 |
| Nov | 6.26 | 5.51 | 6.55 | 15.96 |
| Dec | 6.69 | 6.41 | 7.66 | 16.41 |
EyePoint Pharmaceuticals (EYPT) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 7.54 | 6.76 | 8.02 | 15.71 |
| Feb | 8.21 | 7.43 | 8.82 | 15.74 |
| Mar | 7.80 | 7.45 | 8.84 | 15.76 |
| Apr | 8.13 | 7.10 | 8.67 | 18.17 |
| May | 8.70 | 7.86 | 10.01 | 21.48 |
| Jun | 10.16 | 8.86 | 11.55 | 23.23 |
| Jul | 8.81 | 7.89 | 9.86 | 20.02 |
| Aug | 7.65 | 6.85 | 8.33 | 17.79 |
| Sep | 7.17 | 6.90 | 7.55 | 8.66 |
| Oct | 6.72 | 6.17 | 7.68 | 19.62 |
| Nov | 7.72 | 7.31 | 8.72 | 16.15 |
| Dec | 7.16 | 6.13 | 7.75 | 20.90 |
EyePoint Pharmaceuticals (EYPT) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 7.71 | 7.27 | 8.88 | 18.14 |
| Feb | 8.92 | 8.33 | 9.99 | 16.63 |
| Mar | 9.58 | 8.89 | 10.42 | 14.68 |
| Apr | 9.54 | 8.49 | 10.74 | 20.94 |
| May | 10.00 | 9.18 | 10.49 | 12.49 |
| Jun | 9.26 | 8.47 | 9.96 | 15.01 |
| Jul | 9.70 | 9.25 | 11.10 | 16.60 |
| Aug | 11.54 | 10.79 | 12.83 | 15.89 |
| Sep | 13.21 | 12.23 | 14.41 | 15.15 |
| Oct | 13.31 | 11.54 | 14.52 | 20.55 |
| Nov | 14.97 | 12.84 | 16.23 | 20.87 |
| Dec | 15.91 | 14.10 | 18.06 | 21.93 |
EyePoint Pharmaceuticals (EYPT) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 16.58 | 15.00 | 17.27 | 13.13 |
| Feb | 15.22 | 13.60 | 15.83 | 14.07 |
| Mar | 15.63 | 13.67 | 17.80 | 23.19 |
| Apr | 16.58 | 15.35 | 17.75 | 13.49 |
| May | 15.82 | 13.87 | 17.57 | 21.05 |
| Jun | 15.79 | 15.07 | 17.20 | 12.38 |
| Jul | 15.46 | 13.20 | 16.46 | 19.81 |
| Aug | 15.58 | 13.75 | 17.48 | 21.34 |
| Sep | 17.36 | 14.92 | 18.78 | 20.55 |
| Oct | 18.64 | 17.09 | 19.49 | 12.36 |
| Nov | 20.13 | 19.21 | 20.90 | 8.05 |
| Dec | 20.74 | 19.68 | 22.67 | 13.21 |
EyePoint Pharmaceuticals information and performance
480 PLEASANT STREET, SUITE B300, WATERTOWN, MA, US
Market capitalization of the EyePoint Pharmaceuticals, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of EYPT shares in the company outstanding by the market price of one share.
EBITDA of EyePoint Pharmaceuticals is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
EyePoint Pharmaceuticals (EYPT) stock dividend
EyePoint Pharmaceuticals last paid dividends on 01/01/1970. The next scheduled payment will be on 12/09/2020. The amount of dividends is $0 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.
Last Split Date: 01/01/1970
Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.
For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.
Related stocks from Healthcare sector
